Mu et al. [27] also showed that VRK2 regulated the ERK1/2/AKT signaling pathway by targeting miR-145-5p to inhibit the occurrence and development of lung adenocarcinoma. The gene discussed is MAPK3; the disease is lung adenocarcinoma.